XML 46 R34.htm IDEA: XBRL DOCUMENT
v3.25.3

Business Segment Information (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Segment Reporting [Abstract] |
Schedule of Segment Reporting Information, by Segment | The financial information summarized below is presented by reportable segment for the three months ended September 30, 2025 and 2024:
2025 |  |  |  |  |  |  |  |
(in thousands) |  | Patient Services |  | Device Solutions |  | Corporate/ Eliminations |  | Total
Net revenues - external |  | $ | 22,363 |  | $ | 14,125 |  | $ | — |  | $ | 36,488
Net revenues - internal |  | — |  | 1,944 |  | (1,944) |  | —
Total net revenues |  | 22,363 |  | 16,069 |  | (1,944) |  | 36,488
Significant Segment Expenses: |  |  |  |  |  |  |  |
Supplies and material costs |  | 6,141 |  | 4,734 |  | (1,944) |  | 8,931
Employee-related expenses |  | — |  | 4,043 |  | — |  | 4,043
Depreciation |  | 1,841 |  | 917 |  | — |  | 2,758
Other segment items (a) |  | (101) |  | 37 |  | — |  | (64)
Gross profit |  | 14,482 |  | 6,338 |  | — |  | 20,820
Selling, general and administrative expenses |  |  |  |  |  |  |  | 17,009
Interest expense |  |  |  |  |  |  |  | (330)
Other expense |  |  |  |  |  |  |  | (54)
Income before income taxes |  |  |  |  |  |  |  | $ | 3,427
Total assets |  | $ | 50,610 |  | $ | 46,271 |  | $ | 2,000 |  | $ | 98,881
Purchases of medical equipment |  | $ | 618 |  | $ | 409 |  | $ | — |  | $ | 1,027
Depreciation and amortization of intangible assets |  | $ | 2,148 |  | $ | 1,136 |  | $ | — |  | $ | 3,284
(a) Other segment items included in Segment gross profit include estimates for medical equipment considered to be missing and other miscellaneous shop expenses.
2024 |  |  |  |  |  |  |  |
(in thousands) |  | Patient Services |  | Device Solutions |  | Corporate/ Eliminations |  | Total
Net revenues - external |  | $ | 20,780 |  | $ | 14,540 |  | $ | — |  | $ | 35,320
Net revenues - internal |  | — |  | 1,992 |  | (1,992) |  | —
Total net revenues |  | 20,780 |  | 16,532 |  | (1,992) |  | 35,320
Significant Segment Expenses: |  |  |  |  |  |  |  |
Supplies and material costs |  | 5,075 |  | 5,668 |  | (1,992) |  | 8,751
Employee-related expenses |  | — |  | 4,663 |  | — |  | 4,663
Depreciation |  | 1,755 |  | 825 |  | — |  | 2,580
Other segment items (a) |  | 239 |  | 42 |  | — |  | 281
Gross profit |  | 13,710 |  | 5,335 |  | — |  | 19,045
Selling, general and administrative expenses |  |  |  |  |  |  |  | 15,780
Interest expense |  |  |  |  |  |  |  | (476)
Other expense |  |  |  |  |  |  |  | (4)
Income before income taxes |  |  |  |  |  |  |  | $ | 2,785
Total assets |  | $ | 54,821 |  | $ | 48,482 |  | $ | 2,000 |  | $ | 105,303
Purchases of medical equipment |  | $ | 524 |  | $ | 2,842 |  | $ | — |  | $ | 3,366
Depreciation and amortization of intangible assets |  | $ | 2,037 |  | $ | 1,108 |  | $ | — |  | $ | 3,145
(a) Other segment items included in Segment gross profit include estimates for medical equipment considered to be missing and other miscellaneous shop expenses.
The financial information summarized below is presented by reportable segment for the nine months ended September 30, 2025 and 2024:
2025 |  |  |  |  |  |  |  |
(in thousands) |  | Patient Services |  | Device Solutions |  | Corporate/ Eliminations |  | Total
Net revenues - external |  | $ | 64,655 |  | $ | 42,551 |  | $ | — |  | $ | 107,206
Net revenues - internal |  | — |  | 5,597 |  | (5,597) |  | —
Total net revenues |  | 64,655 |  | 48,148 |  | (5,597) |  | 107,206
Significant Segment Expenses: |  |  |  |  |  |  |  |
Supplies and material costs |  | 17,451 |  | 14,085 |  | (5,597) |  | 25,939
Employee-related expenses |  | — |  | 12,774 |  | — |  | 12,774
Depreciation |  | 5,527 |  | 2,794 |  | — |  | 8,321
Other segment items (a) |  | 207 |  | 104 |  | — |  | 311
Gross profit |  | $ | 41,470 |  | $ | 18,391 |  | $ | — |  | $ | 59,861
Selling, general and administrative expenses |  |  |  |  |  |  |  | 51,655
Interest expense |  |  |  |  |  |  |  | (1,039)
Other expense |  |  |  |  |  |  |  | (41)
Income before income taxes |  |  |  |  |  |  |  | $ | 7,126
Total assets |  | $ | 50,610 |  | $ | 46,271 |  | $ | 2,000 |  | $ | 98,881
Purchases of medical equipment |  | $ | 2,887 |  | $ | 2,454 |  | $ | — |  | $ | 5,341
Depreciation and amortization of intangible assets |  | $ | 6,349 |  | $ | 3,596 |  | $ | — |  | $ | 9,945
(a) Other segment items included in Segment gross profit include estimates for medical equipment considered to be missing and other miscellaneous shop expenses.
2024 |  |  |  |  |  |  |  |
(in thousands) |  | Patient Services |  | Device Solutions |  | Corporate/ Eliminations |  | Total
Net revenues - external |  | $ | 59,617 |  | $ | 41,396 |  | $ | — |  | $ | 101,013
Net revenues - internal |  | — |  | 5,447 |  | (5,447) |  | —
Total net revenues |  | 59,617 |  | 46,843 |  | (5,447) |  | 101,013
Significant Segment Expenses: |  |  |  |  |  |  |  |
Supplies and material costs |  | 14,811 |  | 16,927 |  | (5,447) |  | 26,291
Employee-related expenses |  | — |  | 14,642 |  | — |  | 14,642
Depreciation |  | 5,011 |  | 2,386 |  | — |  | 7,397
Other segment items (a) |  | 366 |  | 130 |  | — |  | 496
Gross profit |  | $ | 39,428 |  | $ | 12,759 |  | $ | — |  | $ | 52,187
Selling, general and administrative expenses |  |  |  |  |  |  |  | 47,912
Interest expense |  |  |  |  |  |  |  | (1,416)
Other expense |  |  |  |  |  |  |  | (64)
Income before income taxes |  |  |  |  |  |  |  | $ | 2,795
Total assets |  | $ | 54,821 |  | $ | 48,482 |  | $ | 2,000 |  | $ | 105,303
Purchases of medical equipment |  | $ | 4,339 |  | $ | 7,823 |  | $ | — |  | $ | 12,162
Depreciation and amortization of intangible assets |  | $ | 5,852 |  | $ | 3,226 |  | $ | — |  | $ | 9,078
(a) Other segment items included in Segment gross profit include estimates for medical equipment considered to be missing and other miscellaneous shop expenses.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration